New York Opens $32 Million Residential Treatment Facility on Wards Island

On a constrained urban site on Wards Island, where the East and Harlem Rivers converge, a new chapter in New York's battle against the opioid crisis began this week with the opening of the Kate Rothko Center for Recovery—a $32 million residential treatment facility representing one of the state's most significant investments in addiction infrastructure in recent years.

The 60-bed facility, operated by Odyssey House and funded through the New York State Office of Addiction Services and Supports (OASAS), offers a comprehensive model of care that integrates medication for addiction treatment (MAT) with withdrawal management, counseling, and what may be its most distinctive feature: a robust expressive arts program rooted in the legacy of its namesake's family.

A New Standard for Residential Treatment

The Kate Rothko Center occupies a three-story, 22,500-square-foot building constructed using modular methods—71 factory-built modules were transported to the island and assembled in just 16 days, a logistical feat that required extensive coordination for oversized loads, bridge access, and escorted transportation through New York City streets. The Dormitory Authority of the State of New York managed the complex project delivery.

What happens inside those walls, however, matters more than how they were built. The facility serves adult men with opioid use disorder, offering methadone, buprenorphine, and naltrexone alongside individual counseling, group therapy, and medical management. This integration of pharmacological and psychosocial interventions reflects an evolving consensus in addiction medicine: medication alone saves lives, but sustained recovery often requires addressing the whole person.

"Every New Yorker deserves access to care that meets them with dignity, compassion and hope," Governor Kathy Hochul said at the facility's opening. "This facility is another example of how New York is investing in the people, programs and infrastructure needed to save lives and support long-term recovery."

The Arts as Medicine

The center's namesake, Dr. Kate Rothko Prizel, brings a unique perspective to addiction treatment. A retired physician specializing in clinical pathology and transfusion medicine, she is also the daughter of celebrated artist Mark Rothko, whose color-field paintings explored the depths of human emotion. As chair of the Odyssey Foundation since 2024, Dr. Rothko Prizel has helped shape a treatment philosophy that draws on her dual heritage in medicine and art.

"My father believed that art could reach people at their most vulnerable and remind them of their own depth," Dr. Rothko Prizel said at the dedication. "I see that same potential in the work of Odyssey House. This center will meet men at their most vulnerable and help restore what addiction has taken from them."

The facility's expressive arts programming—housed in a dedicated studio space—offers residents opportunities for creative engagement alongside traditional therapeutic modalities. This approach aligns with growing research on complementary therapies in addiction treatment, where activities like art, music, and movement can help patients process trauma, develop new coping mechanisms, and discover sources of meaning beyond substance use.

Innovation in Three Areas

Beyond its arts programming, the Kate Rothko Center is committed to developing new models of care in three specific domains. First, the facility is creating a clinical pathway for residents who, under physician guidance, choose to discontinue MAT—a recognition that recovery journeys vary and some patients may eventually transition away from medication.

Second, the center is piloting a recovery coaching model tailored specifically to men receiving MAT in early recovery. This addresses a gap in the existing peer support infrastructure, where coaches with lived experience of medication-assisted treatment remain relatively scarce.

Third, the facility is developing a vocational program designed to address the employment and educational challenges unique to this population—barriers that often persist long after acute withdrawal has subsided and can precipitate relapse if left unaddressed.

Context of New York's Broader Strategy

The Kate Rothko Center opens at a moment of cautious optimism in New York's opioid response. The state has achieved a 44.9% reduction in overdose deaths over three years, with opioid fatalities down 51.9% since 2022—among the steepest declines nationally. Governor Hochul's administration has pursued a multi-pronged strategy combining harm reduction initiatives like the "Harm Reduction Delivered" program—which ships naloxone and supplies directly to residents' homes—with Medicaid reforms expanding access to medication-assisted treatment and primary care integration.

Yet challenges persist. The Bronx and communities of color continue to experience overdose mortality rates above state averages. A new adulterant, medetomidine—colloquially called "rhino tranq"—has been detected in 25% of opioid samples in New York City and was linked to 134 deaths in 2025. The synthetic veterinary tranquilizer, 100 to 200 times more potent than xylazine, creates naloxone-resistant overdose scenarios and complicates both emergency response and withdrawal management.

A Model for Other Jurisdictions?

The Kate Rothko Center represents a particular approach to residential treatment: one that combines evidence-based pharmacotherapy with creative therapeutic modalities, situated within a continuum of care that includes the adjacent George Rosenfeld Center for Recovery. For residents, this means access to expanded medical, dental, and recreational services without leaving the Wards Island campus.

Whether this model can be replicated elsewhere depends on factors ranging from funding availability to workforce capacity to community acceptance of medication-assisted treatment. New York's investment—$32 million in construction costs alone, plus ongoing operational support through OASAS—reflects a level of public commitment that many jurisdictions have struggled to match.

For the men who will pass through its doors, however, the immediate significance is simpler. The Kate Rothko Center offers 60 beds in a city where demand for residential treatment routinely exceeds supply, a place where medication and art coexist in service of recovery, and a reminder that even on a constrained urban site surrounded by water, transformation remains possible.

New Yorkers seeking help for substance use disorders can call the state's 24-hour HOPEline at 1-877-8-HOPENY (1-877-846-7369) or text HOPENY to 467369.